Diagnosis and Management of DHF and Dss
Diagnosis and Management of DHF and Dss
Diagnosis and Management of DHF and Dss
MANAGEMENT OF
DHF AND DSS
____________________
T.H. RAMPENGAN
10/30/2019 1
INTRODUCTION
- DHF relatively new disease in Indonesia
- 1968 in Surabaya and Jakarta
- 1973 in Manado
- Management divided in DHF and DSS
- Mortality rate in : 1968 → 41.3%
1992 → 2.9 %
1995 → 2.5 %
2
DIAGNOSIS WHO 1975 /1986
Based on 4 clinical and 2 laboratoric
criteria
Clinical:
- High fever 2-7 days
- Hemorrhagic manifestation
- Hepatomegaly
- Shock
Laboratoric
- Thrombocytopenia
- Hemoconcentration
DX : Minimally 2 clinical + Lab criteria
The accuracy : 75-90%
3
The severity of disease divided in 4
grade
4
DHF : - ↑ permeability
- Fever ↓ → crisis
DHF I, II :
- Crisis days III >
- IVFD 12 - 24 hours
- PCV ↑, Tr ↓ < 50 000
- Health center / >
5
Fever phase
6
SUBSTITUTION FLUID IN DHF
Maintenance + 5 - 8%
Vomiting every time
Cannot drink
↑ fever
PCV ↑ periodically
Acidosis : NaBic
PCV ↑ > 20% → IVFD : GED mild - mod
7
Table 1. Fluid need for
moderate dehydration
Body Weight Amount of fluid
(Kg) (ml/kgBW/day)
<7 220
7-11 165
12-18 132
>18 88
8
Table 2. Fluid need for maintenance
Body Weight (kg) Amount of fluid
(ml/kgBW/day)
<10 100/kgBW
10-20 1000 + 50/kgBW(>10kg)
>20 1500 +20/kgBW(>20 kg)
9
Temperature ↓ → ↑ leakage
Reconvalescen → Reabsorbtion of fluid
Sign + symptom of shock → hospitalization
Fluid Recommended (WHO)
- Cristaloid: RL-RL- D5%
RA - RA - D5%
NaCl 0,9% - NaCl 0,9% - D5%
- Colloid : Dextran L40
Plasma
10
DSS
Shock→ emergency - fluid →recovery 48 hours
Replacement of plasma volume
- Crystalloid: 20 ml/kgBW/30 min
- Still Shock : Colloid 10-20 ml/kgBW/h
Maximal 30 ml/kgBW
- Improvement : Crystalloid 10-20 ml/kgBW/h
- Still shock, PCV↓ → bleeding → blood
- PCV > 40 → blood 10 ml/kgBW/h
- Massive bleeding → blood 20 ml/kgBW/h
- Improvement → Crystalloid
11
Figure 1. Management of suspect DHF
Suspect DHF
Shock
Torniquet (+) Torniquet (-)
Vomit
Convulsion
Consiousness ↓ Trombocyte Trombocyte
Ambulatory
Hematemesis < 100000/µl > 100000/µl
Paracetamol
Melena
Control until fever ↓
Hospitalization Ambulatory
5 ml/kgBW/H 10 ml/kgBW/H
Evaluation 12-24 H
Step by step
Improvement (+)
15 ml/kgBW/H
3 ml/kgBW/H
Resp Distres Unstable vital sign PCV ↓
PCV ↑
IVFD Stop (24-48)
Colloid Fresh WB
If Vital Sign / PCV
/ Diuresis stable 20-30 ml/kgBW/H 10 ml/kgBW
Improvement
13
Figure 3. Management of DSS (Grade III and IV)
1. Oxygenation
DHF Gr III 2. Plasma volume replacement DHF Gr IV
RL/NaCl 20 ml/kgBW immediately (bolus 30 min)
16
COMPLICATIONS
18
COMPLICATIONS
Common causes of encephalopathy
Hepatic encephalopathy
Severe shock
Inborn error of metab
Hepatotoxic drugs
Underlying liver diseases
Electrolyte imbalance
Metabolic distrubance (hypoglycemia)
Intracranial bleeding
Cerebral thrombosis / ischemia
19
COMPLICATIONS
Management of DHF hepatic encephalopathy
Maintain oxygenation
Prevent ↑ intracranial press:
Restrict IV
Furosemidea+/dexamethasone
↓ Amonia production
Vit K1 3-10 mg IV
Correct metab acidosis
PRC if indicated
Antibiotic
H2 Blocker if massive GI Bleeding
Avoid unnecessary drugs
Exchange tranf if needed
Dyalisis if needed
Branch - chain aminoacid
20
COMPLICATIONS
21
COMPLICATIONS
Dual infections
Associate:
GI, Salmonella
RI, Pneumonia
Urinary infections
Skin + Soft tissure Inf
Nosocomial
Thrombophlebitis
Pneuomonia
UTI (catheter)
Others
Transfusion reaction
Hepatitis
Massive GI Hem
Drugs reactions
22
INDICATION FOR DISCHARGE
Not fever in 24 h
Good appetite
Good general condition
Diuresis
Normal PCV (38-40)
≥ 2 days after shock
No dyspnea
Platelet > 50.000/mm³
No complication
23
CAUSES OF DEATH
Prolonged shock
Fluid overload
Massive bleeding
Unusual manifestation
24